These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2765101)

  • 1. Positive crossmatches--when is it safe to transplant?
    Ting A
    Transpl Int; 1989 Apr; 2(1):2-7. PubMed ID: 2765101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM antibodies in renal transplantation.
    McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
    Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome.
    Taylor CJ; Chapman JR; Ting A; Morris PJ
    Transplantation; 1989 Dec; 48(6):953-8. PubMed ID: 2595783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Relationship to renal transplant outcome.
    Chapman JR; Taylor CJ; Ting A; Morris PJ
    Transplantation; 1986 Dec; 42(6):608-13. PubMed ID: 3538548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
    Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
    Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
    ten Hoor GM; Coopmans M; Allebes WA
    Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
    İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
    Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble HLA antigens and ELISA--a new technology for crossmatch testing.
    Buelow R; Chiang TR; Monteiro F; Cornejo MC; Ellingson L; Claas F; Gaber O; Gelder F; Kotb M; Orosz C
    Transplantation; 1995 Dec; 60(12):1594-9. PubMed ID: 8545896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful kidney transplant in a patient with IgG anti HLA Class-I auto-antibodies: a case report.
    Alhamid N; Alterky H; Almouslem A; Al-Rayess H; Othman MI
    Hum Immunol; 2014 Jul; 75(7):597-601. PubMed ID: 24859192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens.
    Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM
    Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histocompatibility in cardiac transplantation with particular reference to immunopathology of positive serologic crossmatch.
    Singh G; Thompson M; Griffith B; Bernstein R; Rabin BS; Hardesty R; Nalesnik M; Bahnson HT
    Clin Immunol Immunopathol; 1983 Jul; 28(1):56-66. PubMed ID: 6347488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relevance of more sensitive ancillary crossmatch techniques in predicting early cadaver renal graft outcome.
    Smit JA; Stark JH; Margolius LP; Botha JR; Thomson PD; Meyers AM; Myburgh JA
    Transpl Int; 1991 Jun; 4(2):77-81. PubMed ID: 1910433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients.
    Mahoney RJ; Taranto S; Edwards E
    Hum Immunol; 2002 Apr; 63(4):324-35. PubMed ID: 12039415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A positive B cell crossmatch due to IgG anti-HLA-DQ antibody present at the time of transplantation in a successful renal allograft.
    Taylor CJ; Chapman JR; Fuggle SV; Ting A; Morris PJ
    Tissue Antigens; 1987 Sep; 30(3):104-12. PubMed ID: 3321555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.